Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report

Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report

<p>Abstract</p> <p>The complete pathological response after primary chemotherapy could represent an important prognostic factor in patients affected by colorectal liver metastases.</p> <p>In recent studies, increasing complete pathological response seems to be correlate...

Full description

Bibliographic Details
Main Authors:	Luppi Gabriele, Zironi Sandra, Bertolini Federica, Depenni Roberta, Ponti Giovanni, Malavasi Norma, Conte Pier
Format:	Article
Language:	English
Published:	BMC 2009-08-01
Series:	Journal of Hematology & Oncology
Online Access:	http://www.jhoonline.org/content/2/1/35

Similar Items

Triplet Chemotherapy (FOLFOXIRI) Plus Bevacizumab Versus Doublet Chemotherapy (FOLFOX/FOLFIRI) Plus Bevacizumab in Conversion Therapy for Metastatic Colorectal Cancer: a Meta-Analysis
by: Lin Shui, et al.
Published: (2018-08-01)

Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer
by: Valiollah Mehrzad, et al.
Published: (2016-01-01)

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study
by: Portales Fabienne, et al.
Published: (2009-09-01)

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy
by: Bożena Cybulska-Stopa, et al.
Published: (2020-03-01)

A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line Chemotherapy
by: Satoshi Takeuchi, et al.
Published: (2011-05-01)

Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the Literature
by: Chikako Funasaka, et al.
Published: (2019-08-01)

Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01)
by: Suenaga M, et al.
Published: (2015-05-01)

Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
by: Girolamo Ranieri, et al.
Published: (2020-11-01)

Metastatic Urothelial Carcinoma with Glandular Differentiation That Confirmed the Response by Autopsy Specimen to Second-Line mFOLFOX6 (Fluorouracil, Oxaliplatin, and Leucovorin) plus Bevacizumab Chemotherapy
by: Taku Naiki, et al.
Published: (2017-11-01)

Atypical Reversible Leucoencephalopathy Syndrome after Bevacizumab/Folfox Regimen for Metastatic Colon Cancer
by: Narimane Salmi, et al.
Published: (2014-01-01)

Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
by: Girolamo Ranieri, et al.
Published: (2021-02-01)

A Case of Appendiceal Adenocarcinoma with Clinical Benefit from FOLFOX and Bevacizumab
by: Erin D. Powell, et al.
Published: (2009-07-01)

Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab
by: Yuta Ushida, et al.
Published: (2018-08-01)

Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab
by: Mototsugu Matsunaga, et al.
Published: (2016-04-01)

A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy
by: Hiroki Hashida, et al.
Published: (2017-01-01)

MB-6 plus FOLFOX4 for Metastatic Colorectal Cancer
by: Hua-Che Chiang, et al.
Published: (2014)

Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
by: Luiz Carlos Porcello Marrone, et al.
Published: (2013-01-01)

Severe proteinuria during the administration of bevacizumab plus mFOLFOX6 in a colorectal cancer patient after kidney transplantation: a case report
by: Ren Onodera, et al.
Published: (2020-09-01)

All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial
by: Jie Shi, et al.
Published: (2019-04-01)

Complete Response of Pulmonary Metastases from Rectal Cancer to Tegafur-Uracil/Leucovorin plus Bevacizumab in an Elderly Patient: A Case Report
by: Masatsune Shibutani, et al.
Published: (2018-07-01)

Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients
by: Tang N, et al.
Published: (2016-07-01)

Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer
by: Vincenza Conteduca, et al.
Published: (2018-12-01)

Pulmonary Fibrosis Secondary to FOLFOX Chemotherapy: A Case Report
by: Wai Cheong Soon, et al.
Published: (2014-09-01)

Impact of nutritional status in the era of FOLFOX/FIRI-based chemotherapy
by: Shunji Okada, et al.
Published: (2017-08-01)

Multiple liver metastases with synchronous gastric and transverse colon cancer diagnosed by gastric perforation successfully treated by SOX plus bevacizumab and completely resected by surgery: a case report
by: Ryu Matsumoto, et al.
Published: (2020-03-01)

Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer
by: Geva R, et al.
Published: (2013-01-01)

Clinical Significance of has_circ_0055625 in Colon Cancer Patients Undergoing FOLFOX Chemotherapy Treatment
by: Liu X, et al.
Published: (2021-01-01)

Cognitive and physical function in individuals treated with adjuvant FOLFOX chemotherapy for colon cancer : pilot study
by: Niksirat, Negin
Published: (2014)

Quality of life in non-metastasic colorectal cancer patients in FOLFOX or XELOX therapy
by: Julia Sánchez-Gundín, et al.
Published: (2019-03-01)

5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study
by: Hecht JR, et al.
Published: (2015-06-01)

Irinotecan Plus S-1 Followed by Hepatectomy for a Patient with Initially Unresectable Colorectal Liver Metastases, Who Showed Severe Drug Rash with Oxaliplatin Plus 5-FU and Leucovorin (FOLFOX)
by: Hiroyuki Komori, et al.
Published: (2014-01-01)

First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component
by: Yu‐Wen Zhou, et al.
Published: (2021-05-01)

Changes in Body Composition During Adjuvant FOLFOX Chemotherapy and Overall Survival in Non-Metastatic Colon Cancer
by: Eric Chung, et al.
Published: (2019-12-01)

Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases
by: Jordi Remon, MD, et al.
Published: (2021-01-01)

Complete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy
by: Hampig Raphael Kourie, et al.
Published: (2015-01-01)

Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report
by: Zhenyu Lin, et al.
Published: (2018-12-01)

A novel approach to enhancing the effectiveness of chemotherapy : combining curcumin with FOLFOX chemotherapy for metastatic colorectal cancer
by: Irving, Glen Robert Bell
Published: (2014)

mFOLFOX6 Chemotherapy after Resection of Anal Canal Mucinous Adenocarcinoma
by: Mototsugu Matsunaga, et al.
Published: (2016-04-01)

Bevacizumab treatment of meningeal melanoma metastases
by: Trude G. Simonsen, et al.
Published: (2020-01-01)

Complete Pathologic Response of Multiple Liver Metastases and Clinical Complete Response of Rectal Cancer in a Patient with Ataxia-Telangiectasia Mutated Gene Mutations After XELOXIRI Plus Bevacizumab: A Case Report
by: Cheng Y, et al.
Published: (2021-07-01)